Final Tests Planned into Potential Gene Therapy for OPMD, Could Support Trial in Patients
News
Three new animal-model tests of a potential gene therapy for oculopharyngeal muscular dystrophy (OPMD), known as BB-301, are planned, Benitec Biopharma announced. Results are expected to support a request for a Phase ... Read more